CD4 and tuberculosis: After adjusting for age, sex, CD4 count, haemoglobin, and C-reactive protein, receiving LNS-VM was not associated with TB incidence (aHR [95%CI] = 0.93 [0.72–1.20]; p = 0.57) compared to LNS alone.